Literature DB >> 12626892

Assessing the magnitude of the HIV/AIDS epidemic in Burma.

Chris Beyrer1, Myat Htoo Razak, Alain Labrique, Ronald Brookmeyer.   

Abstract

OBJECTIVES: Estimates of the HIV/AIDS burden in Burma (Myanmar) are uncertain. Using data from the 1999 national HIV sentinel surveillance and available population data, we generated estimates of Burma's HIV burden in 1999.
METHODOLOGY: The 1999 sentinel surveillance included women attending antenatal clinics, male military recruits, blood donors, injecting drug users, patients of sexually transmitted disease clinics, and sex workers. We used data for women attending antenatal clinics and male recruits aged 20-29 years to estimate HIV prevalence among women and men, respectively. Data points were merged to give five regional estimates of prevalence for men and women. Census figures were used to obtain national population estimates of the numbers of Burmese living with HIV infection, along with confidence intervals (CIs).
RESULTS: HIV prevalence varied by region, with the lowest rates in the West, intermediate rates in the central region, and highest rates in the North, East, and South. The highest rates were in the East (Shan State), with female prevalence of 3.0% (95% CI, 1.9-4.5). The total number of infected women nationwide was 218,300 (95% CI, 159,400-277,100), and that of men was 468,700 (95% CI, 343,300-594,200). We estimated HIV prevalence of at least 3.46% (95% CI, 2.72-4.19) among adults aged 15-44 years; 5700 infants were born with HIV infection in 1999. DISCUSSION: Burma has a generalized epidemic of HIV-1 in reproductive age adults. We estimated that there were 687,000 (95% CI, 541,100-832,900) Burmese adults living with HIV infection in 1999, or about one of every 29 adult citizens. This estimate is higher than the UNAIDS estimate for the same year of 530,000 adults and children living with AIDS, or a population prevalence of about one in 50 adults. HIV prevention and care programs are urgently needed in Burma.

Entities:  

Mesh:

Year:  2003        PMID: 12626892     DOI: 10.1097/00126334-200303010-00011

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  7 in total

1.  Displacement and HIV: Factors Influencing Antiretroviral Therapy Use by Ethnic Shan Migrants in Northern Thailand.

Authors:  Jordan K Murray; Anthony S DiStefano; Joshua S Yang; Michele M Wood
Journal:  J Assoc Nurses AIDS Care       Date:  2016-04-24       Impact factor: 1.354

Review 2.  Responding to AIDS, tuberculosis, malaria, and emerging infectious diseases in Burma: dilemmas of policy and practice.

Authors:  Chris Beyrer; Voravit Suwanvanichkij; Luke C Mullany; Adam K Richards; Nicole Franck; Aaron Samuels; Thomas J Lee
Journal:  PLoS Med       Date:  2006-10       Impact factor: 11.069

3.  The Parasol Protocol: An Implementation Science Study of HIV Continuum of Care Interventions for Gay Men and Transgender Women in Burma/Myanmar.

Authors:  Andrea L Wirtz; Soe Naing; Emily Clouse; Kaung Htet Thu; Sandra Hsu Hnin Mon; Zin Min Tun; Stefan Baral; Aung Zayar Paing; Chris Beyrer
Journal:  JMIR Res Protoc       Date:  2017-05-17

4.  HIV care in Yangon, Myanmar; successes, challenges and implications for policy.

Authors:  Ne Myo Aung; Josh Hanson; Tint Tint Kyi; Zaw Win Htet; David A Cooper; Mark A Boyd; Mar Mar Kyi; Htin Aung Saw
Journal:  AIDS Res Ther       Date:  2017-03-04       Impact factor: 2.250

5.  An assessment of vulnerability to HIV infection of boatmen in Teknaf, Bangladesh.

Authors:  Rukhsana Gazi; Alec Mercer; Tanyaporn Wansom; Humayun Kabir; Nirod Chandra Saha; Tasnim Azim
Journal:  Confl Health       Date:  2008-03-14       Impact factor: 2.723

6.  HIV prevalence among the female sex workers in major cities in Myanmar and the risk behaviors associated with it.

Authors:  Lin Aung Swe; Abdul Rashid
Journal:  HIV AIDS (Auckl)       Date:  2013-08-28

7.  HIV prevalence and associated factors among foreign brides from Burma in Yunnan Province, China.

Authors:  Yin Xu; Li Ru Fu; Manhong Jia; Genyin Dai; Qing Wang; Peng Huang; Hui Zheng; Zhihang Peng; Lu Wang; Rongbin Yu; Ning Wang
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.